INTRODUCTION
Low-density lipoproteins are implicated in the pathogenesis of atherosclerosis. Much interest has been given to the mechanisms by which LDL uptake by various cell types might be altered, to produce the pattern of cholesterol deposition characteristic of atherosclerosis. Recently, evidence has been accumulating that lipid peroxidation may be a contributory factor in atherogenesis. Enhanced levels of serum lipid peroxides have been measured in individuals at risk (Yagi, 1984) , and there are some data which suggest that lipid peroxidation is involved in cell-mediated modifications to LDL which enhance its endocytosis by macrophages (Steinbrecher et al., 1984) . One way in which this process might affect LDL uptake is by reaction of lipid peroxidation products with the apolipoprotein B moiety. Malondialdehyde has been shown to react with lysine residues in apolipoprotein B, thereby abolishing its affinity for the fibroblast LDL receptor and promoting uptake by the macrophage scavenger receptor (Haberland et al., 1982) . We have recently shown that another product oflipid peroxidation, HNE, also reacts with LDL, and at much lower concentrations than those required for malondialdehyde (Jurgens et al., 1984 (Jurgens et al., , 1985 . We now report on the effects of HNE modification on LDL uptake by the fibroblast LDL receptor.
MATERIALS AND METHODS

Culture of cells
Human skin fibroblasts from normal and homozygous familial hypercholesterolaemic (receptor-deficient) donors were maintained in monolayer culture in a humidified incubator (5% CO2 in air) at 37°C in Eagle's minimal essential medium containing 10% (v/v) heatinactivated foetal calf serum, penicillin (100 units/ml) and streptomycin (100 ,g/ml), and were used between passages 10 and 20. For experiments, the cells were harvested by trypsinization and seeded at near-confluent density ( 
Isolation and modification of lipoproteins
Freshly-drawn blood from normal donors was collected in 2 mM-EDTA and LDL was isolated from the plasma by differential density ultracentrifugation (Havel et al., 1955) between densities of 1.02 and 1.05. HNE was prepared by chemical synthesis as previously described (Esterbauer & Weger, 1967) , and was dissolved in 0.1 M-Tris/HCl (pH 7.5) containing 0.16 M-NaCl, EDTA (1 mg/ml) and chloramphenicol (0.1 mg/ml) (incubation buffer). The exact HNE concentration was determined by A222, with e 13600 M-1 cm-'. LDL was prepared in incubation buffer at various concentrations (22-57 mg/ml); HNE was added in the same buffer to give a final concentration of 1-7 mm, and incubations were performed at 37°C for 4 h under N2, together with control incubations, in which either HNE was omitted (reference LDL) or LDL was omitted (to correct for possible self-decomposition of the aldehyde). Unchanged HNE was removed from LDL by chromatography on Bio-Gel A-i 5m, or by dialysis against several changes of the incubation buffer. Native and modified lipoproteins were routinely labelled with 1251 by the lodogen method (Salacsinski et al., 1981) . The labelled LDLs were separated from low-Mr 125I by chromatography on Sephadex G-25 equilibrated with phosphate-buffered saline containing 0.01 % EDTA, then dialysed against several changes of the same solution at 4°C for 48 h. Immediately before experiments, the labelled and unlabelled lipoproteins were combined to the appropriate specific activity, dialysed for 1 h against phosphatebuffered saline, then sterilized by passage through 0.45,um membrane filters and samples were taken to determine the exact specific radioactivity. Of the radioactivity, 95-99% was precipitable in 10% (w/v) trichloracetic acid. In some experiments, LDL labelled by the ICI method (Bilheimer et al., 1975) was also used; no differences between the uptake properties of LDLs labelled by these alternative methods were found. Lipoprotein-deficient human serum was prepared as described (Knight & Soutar, 1982) .
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Abbreviations used: LDL, low-density lipoprotein; HNE, 4-hydroxy-2,3-trans-nonenal (4-hydroxynonenal); MDA, malondialdehyde. I After removal ofexcess HNE by chromatography on Bio-Gel A-1 5m, material from batch c was reincubated with 3.0 mM-HNE. Table 1 shows the properties of several HNE-modified LDL preparations. HNE reacts with lysine residues of apolipoprotein B, but we also have evidence that other amino acids are involved in the reaction (tyrosine and, to a lesser extent, serine, histidine and cysteine), and also the lipid moiety of the lipoprotein particle (Jurgens et al., 1985) .
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LDLs by human fibroblasts was measured. The amounts of lipoprotein (a) cell-associated and (b) degraded were determined separately. It was found that in normal fibroblasts the HNE-modified LDLs were endocytosed less rapidly than normal LDL, and that the extent of this effect was proportional to the amount of HNE incorporated into the LDL particle. This response was seen both in the incorporation of label in the cells and in the release of degraded materials to the medium (Fig. 1) . The effect of HNE modification on uptake was most pronounced at concentrations of 20 ,tg/ml and below; between 20 and 50 ,ug/ml, the increment in LDL uptake was hardly affected by HNE incorporation. This suggests that HNE modification of LDL alters its affinity for the LDL receptor, without affecting the rate of endocytosis by the low-affinity non-saturable route which predominates at higher lipoproteinconcentrations (Goldstein & Brown, 1974; Knight & Soutar, 1982) . This is supported by the lack of any effect of HNE modification on LDL endocytosis by fibroblasts of a receptor-negative familial hypercholesterolaemic homozygote (Fig. 1) . The competitive inhibition of the internalization and degradation of 125I-labelled normal LDL by various unlabelled preparations of LDL modified with HNE is shown in Fig. 2 and Table 2 . These data also indicate that HNE-modified LDL has a lower affinity for the LDL receptor than has normal LDL, but a similar low-affinity non-saturable rate of uptake.
There was no evidence that HNE-modified LDL is toxic to the cells used in these experiments, as judged by release of the cytosolic enzyme, lactate dehydrogenase, into the medium, or by recovery of cell protein at the end of the incubations.
DISCUSSION
There is increasing evidence that lipid peroxidation is involved in the atherogenic process, and may even be an initiating factor (Yagi, 1984) . Of particular interest are recent reports that the modification in vitro oflipoproteins by cultured endothelial and smooth muscle cells involves lipid peroxidation initiated by free radicals produced by the cells (Steinbrecher et al., 1984; Morel et al., 1984) . In this report we have studied the interaction of one product of lipid peroxidation, HNE, with human LDL, and its effect on the uptake and degradation of LDL. Our results indicate that HNE-modified LDL has a reduced affinity for the fibroblast LDL receptor. This is consistent with several other reports (Goldstein et al., 1979; Gonen et al., 1983; Knight & Soutar, 1982) in which blocking of lysine residues by a range of functional groups lowers the affinity of apolipoprotein B in the LDL particle for its receptor.
Our interest in HNE interaction with LDL lies in the demonstration that this molecule is produced during lipid peroxidation, and is therefore likely to be available in vivo for reaction with LDL in some circumstances, such as during platelet aggregation at sites of arterial injury, or within the LDL particle itself as a result of free radical-initiated peroxidation. Although both MDA and HNE will be generated under such circumstances, HNE was shown to be much more reactive with LDL (Jurgens et al., 1984) . In addition, HNE has a higher lipid solubility than MDA, and therefore may have greater accessibility to regions of the lipoprotein under some circumstances. In preliminary experiments, we have also compared the uptake of normal, HNE-modified, and acetylated LDLs by mouse resident peritoneal macrophages. At the degree of HNE substitution used in the LDL preparations reported in this paper, no enhancement of LDL uptake was observed. However, the most highly substituted LDL contained only 45 mol of HNE-substituted lysine/mol of LDL. This is below the threshold value for recognition of MDA-modified LDL by the macrophage 'scavenger' receptor (Haberland et al., 1982) , and therefore would not be expected to enhance macrophage endocytosis. We are currently studying the endocytosis of more highly substituted LDL preparations to determine whether HNE modification may directly promote macrophage uptake by the 'scavenger' receptor.
The initial effect of modification of LDL by HNE in vivo is likely to be to increase the circulation time of the LDL particle in the plasma and residence time in the subendothelial space. In other instances where circulation is prolonged, such as familial hypercholesterolaemia and diabetes mellitus, the outcome is an increased incidence of atherosclerosis. This may result from increased availability and/or susceptibility of the particle to further modification (by products of lipid peroxidation such as HNE or by other mechanisms) or to the formation of antibodies to the altered LDL. In either case, the net effect is likely to be accelerated endocytosis of the LDL by mononuclear phagocytes, and subsequent foam cell generation. We propose that a similar outcome might result from modification in vivo oflow density lipoproteins by HNE.
